Sjögren syndrome
-
Upload
dattasrisaila -
Category
Health & Medicine
-
view
1.565 -
download
3
Transcript of Sjögren syndrome
![Page 1: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/1.jpg)
Sjögren syndrome
![Page 2: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/2.jpg)
EPIDEMIOLOGY
• It affects primarily females during the fourth and fifth decades of life, with a female-to-male ratio of 9 : 1.
• Sjögren’s syndrome is very common, with a community prevalence of pSS ranging from 0.1% to 0.6% of all individuals.
![Page 3: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/3.jpg)
![Page 4: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/4.jpg)
![Page 5: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/5.jpg)
Major Clinical Manifestations of Sjögren Syndrome
![Page 6: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/6.jpg)
Non-Sicca Manifestations Suggestive of Sjögren Sydrome
![Page 7: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/7.jpg)
CLINICAL FEATURES
Exocrinopathy (glandular involvement) Ocular involvement• The patient usually complains of a burning,
sandy, or scratchy sensation under the lids, itchiness, redness, and photosensitivity.
• Physical signs include dilation of the bulbar conjunctival vessels, pericorneal injection, irregularity of the corneal image, and lacrimal gland enlargement.
![Page 8: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/8.jpg)
Oropharyngeal involvement
• Xerostomia, or dry mouth, results from markedly decreased production of saliva by the salivary glands.
• Other oral symptoms may include soreness, adherence of food to the mucosa, and dysphagia.
![Page 9: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/9.jpg)
• Disappearance of the usual pooling of saliva in the floor of the mouth.
• Surface of the tongue becomes red and lobulated, with partial or complete depapillation.
• In advanced disease, the oral mucosa appears dry and glazed and tends to form fine wrinkles.
![Page 10: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/10.jpg)
Cracked, peeling and atrophic appearance of the lips. Dry and fissured tongue
![Page 11: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/11.jpg)
Dry and smooth tongue. Hyposalivation-related dental caries.
![Page 12: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/12.jpg)
CAUSES OF XEROSTOMIA
1. Psychogenic2. Dehydration3. Diabetes mellitus4. Trauma5. Drugs Psychotherapeutic Parasympatholytic Antihypertensive6. Irradiation7. Congenital (absent or malformed glands)8. Viral infection
![Page 13: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/13.jpg)
• Chronic or episodic swelling of the major salivary glands (parotid and submandibular glands).
• Dryness of the nose, throat, and trachea results in persistent hoarseness and chronic, nonproductive cough.
• Involvement of the exocrine glands of the skin leads to cutaneous dryness.
• Dryness of the vagina and vulva results in dyspareunia and pruritus.
![Page 14: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/14.jpg)
primary Sjögren syndrome with enlarged parotidglands.
![Page 15: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/15.jpg)
DIFFERENTIAL DIAGNOSIS OF PAROTIDGLAND ENLARGEMENT
Bilateral 1. Viral infection (mumps, influenza,
Epstein-Barr, coxsackievirus A, cytomegalovirus,HIV)
2. Sjögren syndrome3. Sarcoidosis4. Miscellaneous (diabetes mellitus,
hyperlipoproteinemia, hepatic cirrhosis,
5. chronic pancreatitis, acromegaly, gonadal hypofunction)
6. Recurrent parotitis of childhood
Unilateral1. Salivary gland neoplasm2. Bacterial infection3. Chronic sialadenitis4. Sialolithiasis
![Page 16: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/16.jpg)
Extraglandular Manifestations
• Primarily generalized arthralgias, is seen in 25–75% of patients.
• Intermittent symmetric arthritis primarily affecting small joints can occur.
• Deformity and mild erosions are rare, except for those cases associated with rheumatoid arthritis.
![Page 17: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/17.jpg)
Small-vessel vasculitis. • The vasculitis may be characterized by either a
lymphocytic vasculitis or leukocytoclastic vasculitis.
• The skin findings include palpable purpura, urticaria, and erythematous macules or papules.
![Page 18: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/18.jpg)
Purpura as an extraglandular manifestation.
![Page 19: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/19.jpg)
Palpable purpura on the lower extremities of a patient with primary
Sjögren syndrome
![Page 20: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/20.jpg)
Nonvasculitic cutaneous lesions• polycyclic, photosensitive cutaneous lesions,
clinically identical to the so-called annular erythema described in Asian SS patients and subacute cutaneous lupus.
![Page 21: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/21.jpg)
Polycyclic, photosensitive cutaneous lesions in a 67-year-old woman with primary SS and anti-Ro/SS-A antibodies.
![Page 22: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/22.jpg)
Lungs• Bronchial/bronchiolar involvement and
interstitial disease can occur.• Anti-Ro antibody positivity is believed to be a
risk factor for pulmonary disease in SS. • Most patients do not develop progressive
pulmonary disease after 10-year follow-up.
![Page 23: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/23.jpg)
Cardiovascular Features• Raynaud phenomenon, with a prevalence of
13%, is probably the most common vascular feature observed in primary SS.
• Vascular complications (eg, digital loss, digital pulp pitting, or fingertip infarctions) are uncommon.
![Page 24: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/24.jpg)
Gut• Gastrointestinal involvement includes altered
esophageal motility, chronic gastritis, and less frequently, malabsorption.
• Liver function tests may be elevated in 10–20% of patients with primary SS.
![Page 25: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/25.jpg)
Nephro-Urologic Involvement• Mild proteinuria in 28%.• Reduced creatinine clearance in 16%.• Distal renal tubular acidosis in 13%.• Interstitial renal disease, characterized by
hyposthenuria and type I (distal) tubular acidosis, and glomerulonephritis.
![Page 26: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/26.jpg)
• Distal tubular acidosis may be clinically silent, but if left untreated, significant renal tubular acidosis may lead to renal stones, nephrocalcinosis, and compromised renal function.
• Patients may present with recurrent renal colic and/or hypokalemic muscular weakness.
• Less commonly, proximal tubular acidosis with Fanconi’s syndrome may occur.
![Page 27: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/27.jpg)
Radiograph of a patient with primary Sjögren syndrome shows
nephrocalcinosis
![Page 28: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/28.jpg)
Neurologic Involvement• Peripheral neuropathy is the most common
neurologic involvement• Pure sensory neuropathy is recognized as a
characteristic neurologic complication of primary SS.
• SS patients may present cranial nerve involvement, mainly of the trigeminal (V), vestibulocochlear (VIII), and facial (VII) cranial pairs.
![Page 29: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/29.jpg)
ASSOCIATION OF SJÖGREN SYNDROME WITHOTHER AUTOIMMUNE RHEUMATIC DISEASES (SECONDARY
SJÖGREN SYNDROME)
1. Rheumatoid arthritis2. Systemic lupus erythematosus3. Scleroderma4. Mixed connective tissue disease5. Primary biliary cirrhosis6. Myositis7. Vasculitis8. Thyroiditis9. Chronic active hepatitis10. Mixed cryoglobulinemia
![Page 30: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/30.jpg)
![Page 31: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/31.jpg)
The Laboratory Evaluation in Sjögren Syndrome
![Page 32: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/32.jpg)
Salivary Gland Biopsy
• Minor salivary gland biopsy is a highly specific test for the diagnosis of SS.
• Focal lymphocytic sialadenitis, defined as multiple, dense aggregates of 50 or more lymphocytes in perivascular or periductal areas in the majority of sampled glands, is the characteristic histopathologic feature of SS
![Page 33: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/33.jpg)
(a) Periductal infiltrates in minor salivary glands (×200).(b) Peritubular infiltrates in a patient with interstitial nephritis (×300).
(c) Peribronchial infiltrates in a patient with small airways disease (×200).(d) Pericholangeal infiltrates in a patient with liver involvement (×200).
![Page 34: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/34.jpg)
Labial salivary gland biopsy specimen from a patient with primary Sjögren syndrome. Focal lymphocytic infiltrates are seen
![Page 35: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/35.jpg)
• Measurement of the salivary flow rate, sialochemistry, sialography, or scintigraphy are done to assess oral involvement.
• Measurement of the salivary flow, with or without stimulation, is the simplest method in evaluating xerostomia, and is acceptable to patients and needs no special equipment.
![Page 36: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/36.jpg)
Sialography showing dilated and distorted ducts (sialectasis). Staging of sialectasia: punctate (< 1 mm) (A), globular (uniform, 1–2 mm) (B), cavitary
(coalescent, > 2 mm) (C), destructive (no structure visible) (D).
![Page 37: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/37.jpg)
Ocular tests
• The main ocular tests are the Schirmer test and rose bengal staining.
• The Schirmer test for the eye quantitatively measures tear formation via placement of filter paper in the lower conjunctival sac.
• The test can be performed with or without the instillation of anesthetic drops to prevent reflex tearing.
• The test result is positive when less than 5 mm of paper is wetted after 5 minutes
![Page 38: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/38.jpg)
Schirmer test in a patient with Sjögren syndrome. Wetting of lessthan 5 mm/5 min of the filter paper strip is shown.
![Page 39: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/39.jpg)
Tear secretion in the left eye and a normal function in the right eye
![Page 40: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/40.jpg)
• Rose bengal scoring involves the placement of 2.5 mL of rose bengal solution in the inferior fornix of each eye and having the patient blink twice.
• Slitlamp examination detects destroyed conjunctival epithelium due to desiccation.
![Page 41: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/41.jpg)
Rose bengal staining (a) in a normal volunteer
In a patient with Sjögren syndrome. Retention of the stain in the cornea is apparent.
![Page 42: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/42.jpg)
The main immunologic markers found in primary SS are
1. Antinuclear antibodies2. Anti-Ro/SS-A3. Anti-La/SS-B antibodies 4. Rheumatoid factor 5. Hypocomplementemia6. Cryoglobulins.
![Page 43: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/43.jpg)
• Antinuclear antibodies are the most frequently detected antibodies in primary SS (in more than 80% of cases), and titers 1:80 play a central role in differentiating SS from non-autoimmune causes of sicca syndrome.
• Anti-Ro/SS-A and La/SS-B antibodies, detected in 30–60% of patients, are closely associated with most extraglandular features, especially with cutaneous lesions, neurologic features, congenital heart block, and cytopenias.
![Page 44: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/44.jpg)
Treatment
• The therapeutic approach is based on symptomatic replacement or stimulation of glandular secretions.
• Extraglandular involvement requires organ-specific therapy, sometimes with glucocorticoids and immunosuppressive agents, as appropriate to the level of severity.
![Page 45: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/45.jpg)
![Page 46: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/46.jpg)
![Page 47: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/47.jpg)
![Page 48: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/48.jpg)
![Page 49: Sjögren syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081416/55505f97b4c905c0448b50b9/html5/thumbnails/49.jpg)
• With regard to biological agents, recent studies have demonstrated the lack of efficacy of tumor necrosis factor inhibitors in primary SS.
• The specific target of rituximab (B cells) suggests that this agent may play a role in modifying the etiopathogenic events of patients with primary SS, a disease characterized by B-cell hyperactivity.